Trials / Completed
CompletedNCT03616119
Gastroesophageal Reflux Disease in Azerbaijan
The Prevalence of Gastroesophageal Reflux Disease in Azerbaijan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Sevda Aghayeva · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended to evaluate the prevalence of the disease in the regions as well as the capital by cluster sampling ,ethitology and to compare the outcomes depending on the geographical location.
Detailed description
It is an observational, nationwide study. The GERD questionnaire (1994) requested from Mayo clinic, was received and validated. The questionnaire was translated by 3 individuals from english to azeri and back trasnlated by 3 native english speakers. Power analysis was performed. The research was presented for the approval to Ethical Committee of Azerbaijan Medical University. Prior to the actual study, a pilot study with smaller number of participants was performed and the results were evaluated. Cluster sampling methodology was provided by the statistical department of Azerbaijan Medical University. 110 employees were hired for using a survey in different regions of Azerbaijan. Written consent was obtained from every person evaluated. Statistical ananlysis was performed.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-08-01
- Completion
- 2019-09-01
- First posted
- 2018-08-06
- Last updated
- 2022-12-13
Locations
1 site across 1 country: Azerbaijan
Source: ClinicalTrials.gov record NCT03616119. Inclusion in this directory is not an endorsement.